Cossette et al., 2022 - Google Patents
Metabolism of anti-inflammatory OXE (oxoeicosanoid) receptor antagonists by nonhuman primatesCossette et al., 2022
View HTML- Document ID
- 5938948052620974305
- Author
- Cossette C
- Chourey S
- Ye Q
- Reddy C
- Wang R
- Poulet S
- Slobodchikova I
- Vuckovic D
- Rokach J
- Powell W
- Publication year
- Publication venue
- European Journal of Pharmaceutical Sciences
External Links
Snippet
Oxo-6, 8, 11, 14-eicosatetraenoic acid (5-oxo-ETE) is the only product of the proinflammatory 5-lipoxygenase pathway with potent chemoattractant effects for human eosinophils, suggesting an important role in eosinophilic diseases such as asthma. 5-Oxo …
- 230000036740 Metabolism 0 title abstract description 42
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Blei et al. | Simultaneous production of psilocybin and a cocktail of β‐carboline monoamine oxidase inhibitors in “magic” mushrooms | |
| Hou et al. | Bioactivity-based liquid chromatography-coupled electrospray ionization tandem ion trap/time of flight mass spectrometry for β2AR agonist identification in alkaloidal extract of Alstonia scholaris | |
| Deng et al. | Identification of amiodarone metabolites in human bile by ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry | |
| Kosina et al. | Identification of benzo [c] phenanthridine metabolites in human hepatocytes by liquid chromatography with electrospray ion-trap and quadrupole time-of-flight mass spectrometry | |
| Li et al. | Non-linear pharmacokinetics of piperine and its herb-drug interactions with docetaxel in Sprague-Dawley rats | |
| Rong et al. | Anesthetic constituents of Zanthoxylum bungeanum Maxim.: A pharmacokinetic study | |
| Shang et al. | An integrated strategy for rapid discovery and identification of the sequential piperine metabolites in rats using ultra high-performance liquid chromatography/high resolution mass spectrometery | |
| Smith et al. | Pharmacokinetics, metabolism, and excretion of [14C] axitinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in humans | |
| Xu et al. | Structural characterization of metabolites of salvianolic acid B from Salvia miltiorrhiza in normal and antibiotic-treated rats by liquid chromatography–mass spectrometry | |
| Tian et al. | Simultaneous determination of eight bioactive compounds by LC-MS/MS and its application to the pharmacokinetics, liver first-pass effect, liver and brain distribution of orally administrated Gouteng-Baitouweng (GB) in rats | |
| Cao et al. | Characterization of chemical constituents and rats metabolites of an alkaloidal extract of Alstonia scholaris leaves by liquid chromatography coupled with mass spectrometry | |
| Ferreres et al. | Simple and reproducible HPLC–DAD–ESI-MS/MS analysis of alkaloids in Catharanthus roseus roots | |
| Wang et al. | Metabolites identification of glycycoumarin, a major bioactive coumarin from licorice in rats | |
| Ma et al. | Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles | |
| Cossette et al. | Metabolism of anti-inflammatory OXE (oxoeicosanoid) receptor antagonists by nonhuman primates | |
| Ye et al. | Novel highly potent OXE receptor antagonists with prolonged plasma lifetimes that are converted to active metabolites in vivo in monkeys | |
| Li et al. | Identification of the cytochrome P450s responsible for the biosynthesis of two types of aporphine alkaloids and their de novo biosynthesis in yeast | |
| Wu et al. | Pharmacokinetic and metabolic profiling studies of sennoside B by UPLC-MS/MS and UPLC-Q-TOF-MS | |
| Mancini et al. | New 1, 2, 3, 4-tetrahydropyrrolo [1, 2-a] pyrimidinium alkaloids (phloeodictynes) from the New Caledonian shallow-water haplosclerid sponge Oceanapia fistulosa. Structural elucidation from mainly LC-tandem-MS-soft-ionization techniques and discovery of antiplasmodial activity | |
| Wang et al. | Identification of ginkgolide B metabolites in urine and rat liver cytochrome P450 enzymes responsible for their formation in vitro | |
| Diao et al. | In-vivo metabolite profiling of chicoric acid in rat plasma, urine and feces after oral administration using liquid chromatography quadrupole time of flight mass spectrometry | |
| Lee et al. | Metabolism of (2S)-pterosin A: identification of the phase I and phase II metabolites in rat urine | |
| Zhao et al. | Pharmacokinetic study of isocorynoxeine metabolites mediated by cytochrome P450 enzymes in rat and human liver microsomes | |
| De Graeve et al. | Metabolism pathway of vinorelbine (Navelbine®) in human: Characterisation of the metabolites by HPLC–MS/MS | |
| Miao et al. | In vitro metabolism of β‐lapachone (ARQ 501) in mammalian hepatocytes and cultured human cells |